Cargando…

Extracorporeal Photopheresis as a Possible Therapeutic Approach for Adults with Severe and Critical COVID-19 Non-Responsive to Standard Treatment: A Pilot Investigational Study

Background: The optimal approach for adult patients hospitalized with severe and critical coronavirus disease 2019 (COVID-19), non-responsive to antiviral and immunomodulatory drugs, is not well established. Our aim was to evaluate feasibility and safety of extracorporeal photopheresis (ECP) in this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szabó, Bálint Gergely, Reményi, Péter, Tasnády, Szabolcs, Korózs, Dorina, Gopcsa, László, Réti, Marienn, Várkonyi, Andrea, Sinkó, János, Lakatos, Botond, Szlávik, János, Bekő, Gabriella, Bobek, Ilona, Vályi-Nagy, István
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10420323/ https://www.ncbi.nlm.nih.gov/pubmed/37568402 http://dx.doi.org/10.3390/jcm12155000

Ejemplares similares

Use of convalescent plasma therapy in hospitalised adult patients with non-critical COVID-19: a focus on the elderly from Hungary
por: Kiss-Dala, Noemi, et al.
Publicado: (2022)

Baricitinib vs tocilizumab treatment for hospitalized adult patients with severe COVID-19 and associated cytokine storm: a prospective, investigational, real-world study
por: Lakatos, Botond, et al.
Publicado: (2022)

Invasive fungal infections among critically ill adult COVID-19 patients: First experiences from the national centre in Hungary
por: Szabo, Balint Gergely, et al.
Publicado: (2021)

Clinical and Microbiological Outcomes and Follow-Up of Secondary Bacterial and Fungal Infections among Critically Ill COVID-19 Adult Patients Treated with and without Immunomodulation: A Prospective Cohort Study
por: Szabó, Bálint Gergely, et al.
Publicado: (2023)

Outcomes of high-risk adult outpatients treated with early remdesivir therapy during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron era: experiences from the national centre of Hungary
por: Gáspár, Zsófia, et al.
Publicado: (2023)

Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection
por: Sinkovits, György, et al.
Publicado: (2021)

Associations between the von Willebrand Factor—ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality
por: Sinkovits, György, et al.
Publicado: (2022)

Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans
por: Vályi-Nagy, István, et al.
Publicado: (2021)

Favipiravir treatment does not influence disease progression among adult patients hospitalized with moderate-to-severe COVID-19: a prospective, sequential cohort study from Hungary
por: Szabo, Balint Gergely, et al.
Publicado: (2021)

Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups
por: Hurler, Lisa, et al.
Publicado: (2023)

559. Efficacy and Tolerability of Integrase Inhibitors: Experiences From a Nationwide Real-Life Cohort
por: Lakatos, Botond, et al.
Publicado: (2018)

Complement Levels at Admission Reflecting Progression to Severe Acute Kidney Injury (AKI) in Coronavirus Disease 2019 (COVID-19): A Multicenter Prospective Cohort Study
por: Henry, Brandon M., et al.
Publicado: (2022)

Extracorporeal Photopheresis—An Overview
por: Cho, Ara, et al.
Publicado: (2018)

Decreased circulating dipeptidyl peptidase-4 enzyme activity is prognostic for severe outcomes in COVID-19 inpatients
por: Nádasdi, Ákos, et al.
Publicado: (2022)

Guidelines on the use of extracorporeal photopheresis
por: Knobler, R, et al.
Publicado: (2014)

Extracorporeal photopheresis: Review of technical aspects
por: Arora, Satyam, et al.
Publicado: (2017)

Beyond 8-methoxypsoralen as the photosensitizer for extracorporeal photopheresis
por: Castillo-Aleman, Yandy Marx
Publicado: (2022)

Effects of Ramadan Fasting on Extracorporeal Photopheresis Outcomes
por: Castillo-Aleman, Yandy M, et al.
Publicado: (2023)

A COVID-19-association-dependent categorization of death causes in 100 autopsy cases
por: Danics, Krisztina, et al.
Publicado: (2021)

Specific Antibody and the T-Cell Response Elicited by BNT162b2 Boosting After Two ChAdOx1 nCoV-19 in Common Variable Immunodeficiency
por: Goda, Vera, et al.
Publicado: (2022)

Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia
por: Kövy, Petra, et al.
Publicado: (2021)

Effect of extracorporeal photopheresis on selected immunologic parameters in psoriasis vulgaris.
por: Vonderheid, E. C., et al.
Publicado: (1989)

Extracorporeal Photopheresis in Children with Chronic Graft-Versus-Host Disease
por: Kozlov, Andrey, et al.
Publicado: (2021)

Extracorporeal photopheresis during the COVID-19 pandemic: experience in Argentina
por: Baquero Rey, Jenny Andrea, et al.
Publicado: (2021)

GVHD treatment with extracorporeal photopheresis in Brazil: a national survey
por: Fatobene, Giancarlo, et al.
Publicado: (2022)

Newly Diagnosed Chronic Lymphocytic Leukemia During Symptomatic COVID-19: Two Cases
por: Papp, Enikő, et al.
Publicado: (2022)

Extracorporeal Photopheresis: Tolerogenic or Immunogenic Cell Death? Beyond Current Dogma
por: Hannani, Dalil
Publicado: (2015)

Successful treatment of Sezary syndrome with extracorporeal photopheresis – The first attempt in India
por: Tiwari, Aseem K., et al.
Publicado: (2019)

A survey of extracorporeal photopheresis treatment in pediatric patients in the United Kingdom
por: Flinn, Aisling M., et al.
Publicado: (2020)

In Vitro and In Vivo Effect of Poplar Bud Extracts on Phytophthora infestans: A New Effective Biological Method in Potato Late Blight Control
por: Turóczi, Botond, et al.
Publicado: (2020)

Human Apoptotic Cells, Generated by Extracorporeal Photopheresis, Modulate Allogeneic Immune Response
por: Pilon, Caroline, et al.
Publicado: (2019)

Thymoma-associated multiorgan autoimmunity treated with multimodal therapy including extracorporeal photopheresis
por: Wheat, Chikoti M., et al.
Publicado: (2021)

Immune Monitoring Assay for Extracorporeal Photopheresis Treatment Optimization After Heart Transplantation
por: Dieterlen, Maja-Theresa, et al.
Publicado: (2021)

Extracorporeal Photopheresis in Addition to Pentostatin in Conditioning for Canine Hematopoietic Cell Transplantation: Role in Engraftment
por: Bethge, Wolfgang A., et al.
Publicado: (2010)

In vitro effects of different 8-methoxypsoralen treatment protocols for extracorporeal photopheresis on mononuclear cells
por: Budde, Holger, et al.
Publicado: (2017)

1088. Extracorporeal Photopheresis and Infectious Complications in Patients with Chronic Graft Versus Host Disease
por: Ashraf, Nida, et al.
Publicado: (2020)

Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial
por: Roberto, Crocchiolo, et al.
Publicado: (2021)

CD11c(+) dendritic cells mediate antigen‐specific suppression in extracorporeal photopheresis
por: Hackstein, H., et al.
Publicado: (2020)

European dermatology forum – updated guidelines on the use of extracorporeal photopheresis 2020 – part 1
por: Knobler, R., et al.
Publicado: (2020)

European dermatology forum: Updated guidelines on the use of extracorporeal photopheresis 2020 – Part 2
por: Knobler, R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8c9e8h0qc8ifnr1vjcb1uv4v05